Development of novel platforms for cancer immunotherapy
The IVTLab is an international and interdisciplinary laboratory promoting cutting-edge research in the field of oncoimmunology and immunotherapy using viruses as platforms to induce and/or orchestrate the tumor-specific immune response. The laboratory is well supported and funded by prestigious and internationally recognised funding agencies such as the European Research Council Consolidator grant (ERC-CoG), HiLIFE, Jane and Aatos Erkko Foundation and Business Finland.
Twitter and News
Professor Vincenzo Cerullo as finalist in Falling Walls 2020
FALLING WALLS AND BERLIN SCIENCE WEEK THE WORLD SCIENCE SUMMIT Falling Walls and Berlin Science Week invites everyone to this year’s World...
Development of pan-corona vaccine against novel pandemic viruses
Professor Vincenzo Cerullo held a talk at Tiedekulma 11th of June, 2020 about the development of a pan-corona vaccine
Members of the ImmunoViroTherapy Lab
The group consists of many experts and researchers with outstanding knowledge in the field of immunovirotherapy.
One of my main priorities is promoting science to non-scientific audience and I believe that it has never been a better time then now to do...
Research: Professor Vincenzo Cerullo email: vincenzo.cerullo(at)helsinki.fi Adminstration: Lab coordinator Katarina Fellman email: katarina...